[Treatment of duodenal and prepyloric ulcers with an antacid and cimetidine either alone or in combination].
In an open randomized study the effectiveness and the acceptance of treatment with a cytoprotective antacidum (226 mval acid-neutralisation-capacity per day's dose) have been examined in 60 patients with clinical and endoscopical secured prepyloric and duodenal ulcera compared with Cimetidine (2x 400 mg) and an initial combination in the first week of treatment. The healing rates depend clearly on the size of ulcus at the beginning of treatment. Ulcera smaller than 8 mm heal in 3 1/2 to 4 weeks up to 71% with the Antacidum, up to 56% to 83% with Cimetidine. For larger ulcera the healing rates are clearly poorer (antacida 20%, Cimetidine 33-67%). Initial combination treatment of the antacidum with Cimetidine for 1 week and the further treatment with the antacidum shows a healing rate of 100% for ulcera smaller than 8 mm, for larger ones a rate of 75%. Therefore the initial combination treatment seems to be useful especially for ulcera duodeni and prepyloric ulcera larger than 8 mm.
D000328:Adult; D000863:Antacids / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004384:Duodenoscopy; D005260:Female; D005773:Gastroscopy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D013276:Stomach Ulcer / Q000188:drug therapy*; D014945:Wound Healing / Q000187:drug effects
D000863:Antacids; D002927:Cimetidine
Die Behandlung duodenaler und präpylorischer Ulzera mit einem Antazidum und Cimetidin jeweils allein und in Kombination.